RESPIRATORY DISEASES - PowerPoint PPT Presentation

1 / 65
About This Presentation
Title:

RESPIRATORY DISEASES

Description:

Title: No Slide Title Author: HEKRON Last modified by: whrhs Created Date: 11/4/2003 10:50:25 PM Document presentation format: On-screen Show Company – PowerPoint PPT presentation

Number of Views:144
Avg rating:3.0/5.0
Slides: 66
Provided by: HEK13
Category:

less

Transcript and Presenter's Notes

Title: RESPIRATORY DISEASES


1
RESPIRATORY DISEASES
PPT HEK SCIENCE DEPT
2
H E A L T H Y
L U N G
3
RESPIRATORY
ASTHMA BRONCHITIS EMPHYSEMA PNEUMONIA ASP.
PNEUMONIA CYSTIC FIBROSIS PNEUMOCONIOSIS ARDS PUL
EMBOLISM PUL INFARCT
DISEASES
4
ASTHMA BRONCHITIS EMPHYSEMA
C O P D
5
(No Transcript)
6
ASTHMA
  • A CHRONIC INFLAMMATORY LUNG DISEASE WITH
    OBSTRUCTION, INFLAMMATION AND HYPER-RESPONSIVENESS
    .
  • SYMPTOMS WHEEZING, DYSPNEA, COUGH AND MUCOID
    SPUTUM.
  • CAUSE IS NOT KNOWN BUT INVOLVES CONTRACTION OF
    MUSCLES, MUCUS AND SWELLING OF AIRWAYS.

7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
Plasma cell
Next time allergens enter the body they are
attracted to IgE on mast cells and cause a
release of histamine which causes
bronchoconstriction and vasodilatation.
Allergensdust pollen, foods.
IgE
antigens
Allergic reaction
IgE attaches to mast and basophil cells
Release of histamine

12
ASTHMA SYMPTOMS
  • WHEEZING
  • CYANOSIS
  • IRRITABLE
  • RESP RATE
  • SWEATING
  • O2 SATlt90-92
  • UNABLE TO TALK MORE THAN A FEW WORDS AT A TIME.

13
PEAK FLOW TEST
PEFR PEAK EXPIRATORY FLOW RATE A DROP IN 50-60
IS INDICATION OF A SEVERE ATTACK.
14
TREATMENT
  • BETA-ADRENERGIC AGENTS - CAUSE BRONCHIAL SMOOTH
    MUSCLE RELAXATION AND INHIBITION OF INFLAMMATORY
    CELLS, SUBSTANCES. (Albuterol).
  • THEOPHYLLINE BRONCHODILATOR. ORIGINALLY
    DERIVED FROM TEA LEAVES.
  • CORTICOSTEROIDS - REDUCE INFLAMMATION.
  • O2 THERAPY
  • ANTIBIOTICS FOR SEC INFECTION.

15
BRONCHITIS
INFLAMMATION OF THE BRONCHI. OFTEN FOLLOWS A COLD
OR ANY INFECTION OF NOSE AND THROAT. AGGRAVATED
BY SMOKING OR SMOKE, DUST AND CHEMICALS IN THE
ENVIRONMENT
16
(No Transcript)
17
BRONCHITIS SYMPTOMS
  • COUGH WORSE IN AM WITH CLEAR MUCOUS SPUTUM.
  • BECOMES THICKER YELLOW IF INFECTION OCCURS
  • FEVER SUGGESTS BACTERIAL INFECTION.

18
MUCOUS PLUG
BRONCHIAL GLAND WITH EXCESS MUCOUS
19
BRONCHITIS TREATMENT
  • REST
  • FLUIDS
  • ANTIPYRETIC FOR FEVERS
  • ANTIBIOTICS FOR PURULENT SPUTUM WHEN HIGH FEVER
    PERSISTS.

20
EMPHYSEMA
  • CHRONIC LUNG DISEASE IN WHICH AIR SACS DEGENERATE
    UNTIL ELASTIC FIBERS ARE DESTROYED. LEADS TO A
    DECREASE IN LUNG ELASTICITY, RESULTING IN
    ACCUMULATION OF CO2 IN THE LUNGS POST EXHALATION.

21
EMPHYSEMA CAUSES AN OVER-INFLATION OF THE ALVEOLI
RESULTING FROM A BREAKDOWN OF THE WALLS WITH
DECREASED RESPIRATORY FUNCTION.
22
DAMAGE TO ALVEOLI IS IRREVERSIBLE AND RESULTS IN
HOLES AND BULLAE IN LUNG TISSUE
MOTH-EATEN APPEARANCE
BULLAE
23
ETIOLOGY
  • SMOKING
  • ADV. STAGE OF BRONCHITIS
  • MAY FOLLOW ASTHMA AND TB
  • ATT-ALPHA 1-ANTITRYPSIN DEFICIENCY RELATED
    EMPHYSEMA

24
HOW SERIOUS IS EMPHYSEMA?
  • 2.8 MILLION AMERICANS
  • RANKS 15th AMONG CHRONIC CONDITIONS TO ACTIVITY
    LIMITATIONS
  • MEN HAVE HIGHER RATES 53 HIGHER THAN FEMALES

25
SYMPTOMS
  • INCREASING SOB
  • COUGH
  • SPUTUM PRODUCTION
  • PROLONGED EXPIRATION
  • ANOREXIA
  • WT LOSS
  • MALAISE

26
SMOKERS LUNG
27
OLD PULMONARY FUNCTION TEST
28
MODERN PFT
29
TREATMENT
  • NO CURE
  • STOP SMOKING
  • BRONCHODILATOR DRUGS
  • ANTIBIOTICS
  • TREAT WITH A1P1 FOR THOSE WHO HAVE DEFICIENCY
  • LUNG TRANSPLANT
  • LUNG VOLUME REDUCTION
  • BREATHING EXERCISES PD

30
EMPHYSEMA PATIENT
31
BARREL CHEST
32
PERCUSSION
33
ARDS
  • A FAILURE OF THE RESP SYS BY FLUID ACCUMULATION
    WITHIN THE LUNGS THAT CAUSE THEM TO STIFFEN.
    CAUSES BLOOD VESSELS TO LEAK INTO THE LUNGS
  • ETIOLOGIES TRAUMA, SHOCK, BLOOD TRANSFUSIONS,
    HEAD INJURY, SMOKE INHALATION AND NEAR DROWNING.
  • UPON XRAY LUNGS BECOME WHITED-OUT

34
ARDS SYMPTOMS TREATMENT
  • RAPID BREATHING
  • NASAL FLARING
  • CYANOSIS
  • DYSPNEA
  • ANXIETY AND STRESS
  • APNEA AT TIMES
  • RALES, RHONCHI AND WHEEZES
  • SURVIVAL RATE IS 50 WITH 90 HAVINGA CARDIAC
    ARREST
  • O2 AT 100 IS ADMINISTERED INTUBATION AND
    MECHANICAL VENTILATION
  • MEDS TO REDUCE INFLAMMATION

35
ASPIRATION PNEUMONIA
36
ASPIRATION PNEUMONIA
  • ABNORMAL ENTRY OF FLUIDS VOMIT, BILE, ACIDS
    INTO THE LUNGS.
  • TAKES COURSE SIMILAR TO ARDS
  • SAME TYPE OF TREATMENT IS REQUIRED TO GIVE
    RESPIRATORY SUPPORT WITH O2 AND MECHANICAL
    VENTILATION.
  • FREQUENT SUCTIONING IS DONE EARLY IN THE COURSE
    OF TREATMENT.
  • ANTIBIOTICS FOR ANAEROBIC BACTERIA

37
PNEUMONIA
  • INFLAMMATION OF THE LUNGS DUE TO BACT, VIRUSES OR
    CHEM IRRITANTS
  • MOST COMMON TYPE IS BACT PNEUMONIA FROM STREP.
    PNEUMONIAE
  • OCCURS WHEN THE BODY IS WEAKENED FROM ILLNESS,
    MALNUTRITION, OLD AGE

38
(No Transcript)
39
SYMPTOMS
  • CHILLS, HIGH FEVER
  • CHEST PAIN
  • PRUNE COLORED SPUTUM
  • SWEATING
  • RAPID PULSE AND BREATHING
  • CYANOSIS
  • CONFUSED MENTAL STATE.

40
TREATMENT ANTIBIOTICS, O2, NEBULIZER, POSTURAL
DRAINAGE, NUTRITION, FLUIDS VACCINES.
41
VACCINATION
NEXT
42
PNEUMOCONIOSESOCCUPATIONAL DISEASES
  • INHALATION OF PARTICLES DUSTS, SILICA, ASBESTOS,
    COAL, IRON OXIDES, COTTON, FLAX
  • PARTICLES DEPOSITED DEPEND ON SEDIMENTATION,
    INERTIAL IMPACTION AND DIFFUSION

43
PATHOLOGY OF DISEASE
INHALED PARTICULATES
PROLIFERATIONOF CONNECTIVE TISSUE DUE TO
IRRITATION
COLLAGEN FORMATION COALESCING OF NODULES
END RESULT IS LUNG AND HEART FAILURE
44
NODULE OF DUST
45
TYPES OF PNEUMCONIOSES
  • SILICOSIS
  • ASBESTOSIS
  • ANTHRACOSIS
  • SIDEROSIS
  • BAGASOSSIS
  • BYSSINOSIS

ASBESTOS FIBERS
46
SYMPTOMS
  • SOB RELATED TO SIZE OF NODULES
  • WHEEZING
  • COUGH
  • DYSPNEA
  • WEIGHT LOSS
  • EXCESS SPUTUM
  • REDUCED EXERCISE TOLERANCE

47
TREATMENT
  • DUST SUPPRESSION
  • TREAT SYMPTOMS
  • SIMILAR TO COPD TREATMENT
  • ANTIBIOTICS FOR SEC. INFECTION
  • O2 THERAPY
  • NEB AND STEROIDS

CITY LUNG
48
(No Transcript)
49
CYSTIC FIBROSIS
  • INHERITED AUTOSOMAL RECESSIVE TRAIT OCCURRING IN
    ABOUT 5 OF POP.
  • A DISEASE OF EXOCRINE GLANDS WHICH HYPER-SECRETE
    PRIMARILY AFFECTING RESPIRATORY AND GI SYSTEMS
  • MOST COMMON LETHAL GENETIC DIS. IN WHITE POP.

50
(No Transcript)
51
SYMPTOMS
ABN SWEAT AND MUCOUS GLANDS WITH LOSS OF NaCl CAN
CAUSE ELECTROLYTE IMBALANCE, ARRHYTHMIAS,
SHOCK. THICK MUCOUS CAUSES RESP INFECTION,
DYSPNEA, LUNG DISEASE, MALNUTRITION POOR GROWTH.
52
CHEST PHYSICAL THERAPY
53
NEBULIZER DELIVERY OF BRONCHODILATORS
54
TREATMENT OF CF
  • PT
  • EXERCISE TO LOOSEN MUCUS AND STIMULATE COUGHING
  • BRONCHODILATORS
  • O2 THERAPY
  • ANTIBIOTICS FOR SEC. INF.
  • NUTRITION AND VITAMINS
  • LUNG TRANSPLANT

55
PULMONARY EMBOLUS
  • SUDDEN LODGEMENT OF A BLOOD CLOT WITH OBSTRUCTION
    OF BLOOD SUPPLY TO THE LUNG PARENCHYMA.
  • CAN LEAD TO NECROSIS OF LUNG TISSUE PUL. INFARCT

56
SYMPTOMS TREATMENT
  • SYMPTOMSVARY IN FREQ. INTENSITY
  • TACHYPNEA
  • SUBSTERNAL CHEST PAIN
  • HYPOXEMIA
  • TREATMENT ANALGESICS, HEPARIN (WATCH FOR
    BLEEDING), O2, SEDATIVES, PUL. EMBOLECTOMY.

57
PhotoGallery
anthracosis
bulbous emphysema
bronchopneumonia
58
PhotoGallery
CF bronchiectasis
59
PhotoGallery
emphysema
60
PhotoGallery
Pul embolus
Pul infarct
61
PhotoGallery
pneumonia
62
PhotoGallery
siderosis
63
PhotoGallery
Status asthmaticus
64
PhotoGallery
TB
Lung transplant
65
ACKNOWLEDGEMENTS
  • www.pediatriconall.com
  • www.courier-journal.com
  • www.fpnotebook.com
  • www.itc.csmd.edu
  • //krupp.wcc.hawaii.edu
  • www.merck.com
  • med-lab.utah.edu
Write a Comment
User Comments (0)
About PowerShow.com